Sam Jactel, MBA is the CEO & Founder of Ayble Health, an award-winning digital digestive health platform helping manage symptoms, improve quality of life and reduce healthcare costs for GI patients through nutrition and behavioral health interventions and health coaching. In 2014, he was diagnosed with Inflammatory Bowel Disease, and with Ayble, he’s building the solution he wished had existed when he was diagnosed. In addition to building and scaling Ayble, Sam currently serves on the review board for the Department of Defense’s Congressionally Directed Medical Research Program for IBD, helping allocate $400M to find a cure for Crohn’s Disease and Ulcerative Colitis. Prior to Ayble, Sam was a venture capital investor, startup leader, healthcare consultant and clinical researcher. Sam is a graduate of Duke University and Kellogg School of Management at Northwestern, where he was a Zell Fellow.